Daniel Schmitt
Vorstandsvorsitzender bei Actuate Therapeutics, Inc.
Vermögen: 10 $ am 30.04.2024
Profil
Daniel M.
Schmitt's former job positions include Director-Academic Partnerships at First Genetic Trust, Inc. and SVP-Licensing & Commercial Development at Immtech Pharmaceuticals, Inc. He obtained his undergraduate degree and MBA from West Virginia University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. 2,63% | 01.05.2024 | 1 003 421 ( 2,63% ) | 10 $ | 30.04.2024 |
Aktive Positionen von Daniel Schmitt
| Unternehmen | Position | Beginn |
|---|---|---|
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Vorstandsvorsitzender | 01.03.2015 |
Ehemalige bekannte Positionen von Daniel Schmitt
| Unternehmen | Position | Ende |
|---|---|---|
First Genetic Trust, Inc.
 First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Immtech Pharmaceuticals, Inc.
 Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Daniel Schmitt
| West Virginia University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Immtech Pharmaceuticals, Inc.
Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Health Technology |
First Genetic Trust, Inc.
First Genetic Trust, Inc. Medical/Nursing ServicesHealth Services First Genetic Trust, Inc. provides genetic data handling and bioinformatics services to pharmaceutical companies, medical researchers and health care providers. The company was founded in 2000 by Arthur L. Holden and is headquartered in Deerfield, IL. | Health Services |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
